Key result
Multi-channel testing outperforms isolated hERG screening for predicting in vivo arrhythmia risk.
Why the study?
Testing new compounds for pro-arrhythmic potential has focused on avoiding activity at the hERG K+ channel due to its association with Torsades de Pointes and long QT syndrome.
Comprehensive preclinical screening of hERG and other ion channels is essential for predicting the pro-arrhythmic risk of new pharmacological compounds.
Answers are grounded in this paper and cite their sources.
Supports integrated multi-channel screening in preclinical drug safety; leaves open prospective validation for clinical arrhythmia prediction.
Testing new compounds for pro-arrhythmic potential has focused in recent years on avoiding activity at the hERG K+ channel, as hERG block is a common feature of many pro-arrhythmic compounds associated with Torsades de Pointes in humans. Blockers of hERG are well known to prolong cardiac action potentials and lead to long QT syndrome, and activators, although rarer, can lead to short QT syndrome. The most reliable assays of hERG utilize stable cell lines, and include ligand binding, Rb+ flux and electrophysiology (both automated and manual). These assays can be followed by measurement of activity at other ion channels contributing to cardiac contractility and detailed action potential/repolarization measurements in cardiac tissue. An integrated risk assessment for pro-arrhythmic potential is ultimately required, as the constellation of ion channel activities and potencies, along with the mechanism/kinetics of ion channel block, may ultimately be the best predictor of cardiac risk in vivo.
No takes yet. Share an insight, caveat, or question.
Bowlby et al. (2008) conducted a review in Cardiac arrhythmia risk. hERG K+ channel screening assays was evaluated. An integrated risk assessment of hERG K+ channel block and other ion channel activities is required to predict in vivo cardiac arrhythmia risk.
Synapse has enriched 10 related papers. Consider them for comparative context: